Aspartic acid unveils as antibiofilm agent and tobramycin adjuvant against mucoid and small colony variants of Pseudomonas aeruginosa isolates in vitro within cystic fibrosis airway mucus
Antibiotics are central to managing airway infections in cystic fibrosis (CF), yet current treatments often fail due to the presence of Pseudomonas aeruginosa biofilms, settling down the need for seeking therapies targeting biofilms. This study aimed to investigate the antibiofilm activity of aspart...
Saved in:
| Main Authors: | Rosana Monteiro, Ana Margarida Sousa, Maria Olívia Pereira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Biofilm |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590207524000777 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic Insights into Succinic Acid as an Adjuvant for Ciprofloxacin in Treating <i>Pseudomonas aeruginosa</i> Growing Within Cystic Fibrosis Airway Mucus
by: Rosana Monteiro, et al.
Published: (2024-12-01) -
Comparison of in vitro antimicrobial susceptibility between mucoid and non-mucoid Pseudomonas aeruginosa and its guiding value for antibiotic therapy
by: Yun Wu, et al.
Published: (2025-07-01) -
Effect of daphnetin combined with tobramycin on Pseudomonas aeruginosa biofilm infection in vitro and in vivo
by: Dingbin Li, et al.
Published: (2025-08-01) -
Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria
by: Guergana Petrova, et al.
Published: (2016-11-01) -
Pseudomonas aeruginosa increases viscoelasticity and decreases transportability of artificial mucus
by: Caitlin Costello, et al.
Published: (2025-09-01)